Featured

24 January 2024

ACCORD: new guideline to support consistent and complete reporting of consensus methods in biomedical research

Oxford PharmaGenesis has contributed to the development of the new ACCORD reporting guideline to help the medical and scientific communities to improve the reporting of research involving consensus methodologies. The guideline was published in the non-profit open access journal PLOS Medicine.

All
  • All
  • News
  • Articles
  • Events

Oxford PharmaGenesis takes part in capacity building and health literacy panel at 13th Annual eyeforpharma Patient Summit Europe

On 17–18 October, more than a hundred patients, patient advocates and representatives from pharma gathered in London, UK, for the 13th Annual eyeforpharma Patient Summit Europe to discuss the importance of patient centricity in the pharmaceutical industry.

Continue reading

Oxford PharmaGenesis at Medical Affairs Leaders Forum – Autumn 2016

Oxford PharmaGenesis was delighted to attend the Medical Affairs Leaders Forum in London, UK on 18–20 October. This meeting brought together medical affairs professionals and related industry staff and academics from Europe and beyond for 3 days of presentations, discussions and networking.

Continue reading

32nd Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)

[vc_row][vc_column][vc_column_text]14­–17 September 2016, London, UK These are exciting times in the field of multiple sclerosis (MS) management; the past 5 years have seen an explosion in the number of disease-modifying therapies (DMTs) licensed for the treatment of patients with relapsing–remitting MS (RRMS).

Continue reading

Oxford PharmaGenesis at MASS West 2016

The 2016 Medical Affairs Strategic Summit (MASS) West began on 14 September in San Diego, California, USA. The 3-day summit hosted professionals involved in all aspects of medical affairs including clinical research, health economics, key opinion leadership, medical communications and publication planning.

Continue reading

Oxford PharmaGenesis delivers global educational webinar on patient-reported outcomes, health literacy and patient centricity

Oxford PharmaGenesis insights into patient-reported outcomes (PROs), health literacy and patient-centricity were the subject of the September edition of the International Society for Medical Publication Professionals (ISMPP) online education series, ISMPP University (ISMPP U).

Continue reading

Local HealthScience consultancy welcomes Ed Vaizey MP

[vc_row][vc_column][vc_column_text]Today, the Right Honourable Edward Vaizey, local MP for Wantage, visited award-winning HealthScience communications consultancy Oxford PharmaGenesis to discuss the implications of Brexit for trade, education, research and health funding in Oxfordshire.

Continue reading